Hepatic stimulator substance administration ameliorates liver regeneration in an animal model of fulminant hepatic failure and encephalopathy

Liver International

Volumn 23, Issue 3, 2003, Pages 171-178

  Margeli, Alexandra P ^a,b   Papadimitriou, Lila ^a   Ninos, Sotirios ^a   Manolis, Evangelos ^b   Mykoniatis, Michael G ^a   Theocharis, Stamatios E ^a,c  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b UNIVERSITY OF ATHENS   (Greece)

^c Nursing School ^*  (Greece)

Author keywords

Fulminant hepatic failure; Hepatic encephalopathy; Hepatic stimulator substance; Liver injury; Liver regeneration

Indexed keywords

AMMONIA; DNA; GROWTH FACTOR; LIVER ENZYME; LIVER PROTECTIVE AGENT; THIOACETAMIDE; THYMIDINE KINASE; UREA;

AMMONIA BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ACTIVITY; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; DISEASE MODEL; DNA SYNTHESIS; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; HEPATIC ENCEPHALOPATHY; HISTOPATHOLOGY; LIVER CELL; LIVER FAILURE; LIVER PROTECTION; LIVER REGENERATION; MALE; MITOSIS; NONHUMAN; OUTCOMES RESEARCH; RAT; RAT STRAIN; STATISTICAL SIGNIFICANCE; UREA BLOOD LEVEL;

EID: 0142124728     PISSN: 14783223     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0676.2003.00828.x     Document Type: Article

References (54)

1. O'Grady J, Schalman S W, Williams R. Acute liver failure: redefining the syndrome. Lancet 1993; 324: 273-5.
2. Lee W R. Acute liver failure. N Engl J Med 1993; 329: 1867-72.
3. Ferenci P. Treatment of hepatic encephalopathy. Indian J Gastroenterol 2001; 20: C90-4.
4. Blei A T. Diagnosis and treatment of hepatic encephalopathy. Baillieres Best Pract Res Clin Gastroenterol 2000; 14: 959-74.
5. Riordan S M, Williams R. Acute liver failure: targeted artificial and hepatocyte-based support of liver regeneration and reversal of multiorgan failure. J Hepatol 2000; 32: 63-76.
6. Van Thiel D H, Brems J, Nadir A, et al. Liver transplantation for fulminant hepatic failure. J Gastroenterol 2001; 36: 1-4.
7. Zimmermann C, Ferenci P, Pifl C, et al. Hepatic encephalopathy in thioacetamide induced acute liver failure in rats: characterization of an improved model and study of amino acid-ergic neurotransmission. Hepatology 1989; 9: 595-601.
8. Larsen F S, Knudsen G M, Paulson O B, et al. Cerebral blood flow autoregulation is absent in rats with thioacetamide-induced hepatic failure. J Hepatol 1994; 21: 491-5.
9. Bruck R, Aeed H, Shirin H, et al. The hydroxyl radical scavengers dimethylsulfoxide and dimethylthiourea protects rats against thioacetamide-induced fulminant hepatic failure. J Hepatol 1999; 31: 27-38.
10. Chieli E, Malvaldi G. Role of the microsomal FAD-containing monooxygenase in the liver toxicity of thioacetamide S-oxide. Toxicology 1984; 31: 41-52.
11. Porter W R, Neal R A. Metabolism of thioacetamide and thioacetamide S-oxide by rat microsomes. Drug Metab Dispos 1978; 6: 379-88.
12. Fleig W E. Liver specific growth factors. Scand J Gastroenterol 1988; 23: 31-6.
13. Labrecque D R, Pesh L A. Preparation and partial characterization of hepatic regenerative stimulator substance (SS) from rat liver. J Physiol 1975; 248: 273-84.
14. Fleig W E, Lehmann H, Wagner H, et al. Hepatic regenerative stimulator substance in the rabbit. Relation to liver regeneration after partial hepatectomy. J Hepatol 1986; 3: 19-26.
15. Francavilla A, Ove P, Polimeno L, et al. Extraction and partial purification of hepatic stimulatory substance in rats, mice and dogs. Cancer Res 1987; 47: 5600-5.
16. Mao-Hua M, Wei A, Bao-Hong Z, et al. Hepatic stimulator substance protects against acute liver failure induced by carbon tetrachloride poisoning in mice. Hepatology 1993; 17: 638-44.
17. Zhiqiang Y, Weisong Y, Wenbin Z, et al. Hepatic stimulator substance from human fetal liver for treatment of experimental hepatic failure. Chinese Med J 1992; 105: 676-83.
18. Margeli A, Theocharis S, Spiliopoulou C, et al. Hepatic stimulator substance administration affects cadmium-induced hepatotoxicity in the rat. Int Hepatol Commun 1996; 5: 128-34.
19. Theocharis S E, Margeli A P, Agapitos E V, et al. Effect of hepatic stimulator substance administration on tissue regeneration due to thioacetamide induced liver injury in rats. Scand J Gastroenterol 1998; 33: 656-63.
20. Theocharis S E, Margeli A P, Spiliopoulou C, et al. Hepatic stimulator substance administration enhances the regenerative capacity of hepatocytes in cadmium-pretreated partially hepatectomized rats. Dig Dis Sci 1996; 41: 1475-80.
21. Geller D. A rat model of hepatic encephalopathy due to fulminant hepatic failure: the role of supportive therapy. In: Soeters P B, Wilson I H P, Meijer A J, Holm E, eds. Advances in Ammonia Metabolism and Hepatic Encephalopathy. Amsterdam: Elsevier Science Publishers, 1988; 213-7.
22. International federation of clinical chemistry: committee on standards, enzyme panel. Clin Chem 1978; 24: 720-1.
23. Moss D W, Henderson A R, Kachmar J F. Enzymes. In: Tietz N W, ed. Textbook of Clinical Chemistry. Philadelphia PA: W.B. Saunders Company, 1995; 706-13.
24. Rock R C, Walker W G, Jennings C D. Nitrogen metabolites and renal function. In: Tietz N W, ed. Textbook of Clinical Chemistry. Philadelphia PA: W.B. Saunders Company, 1995; 1268-71.
25. Balisteri W F, Shaw L M. Liver function. In: Tietz N W, ed. Textbook of Clinical Chemistry. Philadelphia PA: W.B. Saunders Company, 1995; 1411-2.
26. Munro H N, Fleck A. Recent developments in the measurement of nucleic acids in biological materials. Analyst 1966; 91: 78-88.
27. Richards G M. Modifications of the diphenylamine reaction giving increased sensitivity and simplicity in the estimation of DNA. Anal Biochem 1974; 57: 369-76.
28. Kahn D, Svanas G, Eagon P, et al. Effect of an antiandrogenic H2 receptor antagonist on hepatic regeneration in rats. J Laboratory Clin Med 1988; 112: 232-9.
29. Lowry O H, Rosebrough N J, Farr A L, et al. Protein measurement with the Folin phenol reagent. J Biol Chem 1951; 193: 265-75.
30. Labrecque D R, Feigenbaum A, Bachur N R. Diurnal rhythm: effects on hepatic regeneration and hepatic regenerative stimulator substance. Science 1978; 199: 1082-4.
31. Labrecque D R, Steele G, Fogerty S, et al. Purification and physical-chemical characterization of hepatic stimulator substance. Hepatology 1988; 7: 100-6.
32. Labrecque D R, Bachur N R. Hepatic stimulator substance: physicochemical characteristics and specificity. Am J Physiol 1982; 242: G281-8.
33. Higgins G M, Anderson R M. Experimental pathology of the liver. Restoration of the liver of the white rat following partial surgical removal. Arch Pathol 1931; 12: 186-201.
34. Mullen K D. Evaluation of the suitability of galactosamine-induced fulminant hepatic failure as a model of hepatic encephalopathy in the rat and rabbit. In: Soeters P B, Wilson J H P, Meijer A J, Holm E, eds. Advances in Ammonia Metabolism and Hepatic Encephalopathy. Amsterdam: Elsevier Science Publishers, 1988; 205-11.
35. Margeli A, Theocharis S, Skaltsas S, et al. Effect of cadmium pretreatment on liver regeneration after partial hepatectomy in rats. Arch Toxicol 1994; 68: 85-90.
36. Jiang B, Sawa M, Yamamoto T, et al. Enhancement of proliferation of intrasplenically transplanted hepatocytes in cirrhotic rats by hepatic stimulatory substance. Transplantation 1997; 63: 131-5.
37. Margeli A P, Skaltsas S D, Spiliopoulou C A, et al. Hepatic stimulator substance activity in the liver of thioacetamide-intoxicated rats. Liver 1999; 19: 519-25.
38. Kyprianidis K G, Mykoniatis M G, Papadimitriou D G, et al. Effect of subtotal pancreatectomy on the rate of liver regeneration. The role of hepatic stimulator substance. J Surg Res 1996; 62: 267-72.
39. Liakos A A, Mykoniatis M G, Kokala M E, et al. Levels of hepatic stimulator substance in liver regenerating process of partially hepatectomized rats pretreated with a single dose of carbon tetrachloride. Dig Dis Sci 1999; 44: 1046-53.
40. Wei A, Mao-Hua M. A study of the protective mechanism of hepatic stimulator substance against experimental acute liver failure in mice. Acta Physiol Sinica 1992; 44: 54-61.
41. Hwang T L, Yu H C, Chen P C, et al. Liver regeneration following partial hepatectomy and stimulation by hepatic stimulatory substance in cirrhotic and non cirrhotic rats. Res Exp Med (Berl) 1995; 195: 201-8.
42. Zhang B H, Gong D Z, Mei M H. Protection of regenerating liver after partial hepatectomy from carbon tetrachloride hepatotoxicity in rats: role of hepatic stimulator substance. J Gastroenterol Hepatol 1999; 14: 1010-7.
43. Liu X J, An W, Lei T G, et al. Regulatory effect of hepatic stimulator substance on the proliferation of human hepatoma cells. Sheng Li Bao 1998; 50: 543-50.
44. An W, Liu X J, Lei T G, et al. Growth induction of hepatic stimulator substance in hepatocytes through its regulation on EGF receptors. Cell Res 1999; 9: 37-49.
45. Jiang B, Kasai S, Sawa M, et al. Beneficial effect of hepatic stimulatory substances on the survival of intrasplenically transplanted hepatocytes. Cell Transpl 1993; 2: 325-9.
46. Fleig W E, Hoss G. Partial purification of rat stimulator substance and characterization of its action on hepatoma cells and normal hepatocytes. Hepatology 1989; 9: 240-8.
47. Zhiqiang Y, Weisong Y, Wenbin Z, et al. Human hepatic regenerative stimulator substance: partial purification and biological characterization of hepatic stimulator substance from human fetal liver cells. Hepatology 1990; 12: 1144-51.
48. Yao Z Q, Yang W S, Chen B F, et al. Purification and characterization of human hepatic stimulator substance. Chin J Med (Engl) 1993; 106: 527-32.
49. 4-intoxication dissociated hepatocytes. Sheng Li Xue Bao 1993; 45: 387-94.
50. Yao Z Q, Yang W S, Zhang W B, et al. Hepatic stimulator substance from human fetal liver for treatment of experimental hepatic failure. Chin Med J (Engl) 1992; 105: 676-83.
51. Zhiqiang Y, Weisong Y, Benfu C, et al. Purification and characterization of human hepatic stimulator substance. Chinese Med J 1993; 106: 527-32.
52. Guillaume D, Clamon L, Labrecque D R. Hepatic stimulator substance (HSS) stimulates phosphoinositol hydrolysis (Abstract). Hepatology 1996; 24: 362A.
53. Chen L, An W, Tan X, et al. Phosphorylation of hepatic stimulator substance on mitogen-activated protein kinase in BEL-7402 hepatoma cells. Zhonghua Gan Zang Bing Za Zhi 2001; 9: 22-4.
54. He F, Wu C, Tu Q, et al. Human hepatic stimulator substance: a product of gene expression of human fetal liver tissue. Hepatology 1993; 17: 225-9.